References
- Schiff BL, Kern AB. Cutaneous reactions to anticoagulants. Arch Dermatol 196898:136–7
- Koch-Weser J. Coumarin necrosis. Ann Intern Med 1968:68:1365–7
- Horn JR, Danzinger LH, Davis RJ. Warfarin-induced skin necrosis: report of four cases. Am J Hosp Pharm 1981:38:1763–8
- Feder W, Auerbach R. “Purple toes”: an uncommon sequela of oral coumarin drug therapy. Ann Intern Med 1961:55:911–7
- Rand H. Purple toes as a complication of oral anticoagulants. In: Nichols AS, Bradley MH, Elias RA, et al, eds. Anticoagulant therapy in ischemic heart disease. New York: Grune & Stratton. 1965:437–8
- Mayer GA. In: Nichols et al, eds.4 pp 452–60 (discussion)
- Di Cato MA. “Purple toes” syndrome: an uncommon complication of oral anticoagulant therapy. Postgrad Med 1975:58(7):133–4
- Jones RR, Cunningham J. Warfarin skin necrosis: the role of factor VII. Br J Dermatol 1979:101:561–5
- Bruinsma W. A guide to drug eruptions: the file of adverse reactions to the skin. Amsterdam: Netherlands. Krips Repro. Meppel. 1977
- Adams CW, Pass BJ. Extensive dermatitis due to warfarin sodium (Coumadin). Circulation 1960:22:947–8